The practice at Sidley Austin LLP has ‘great experience in investment arbitrations’, acting on high-value, cross-border mandates. Blue-chip clients, governments, and multinational corporations all rely on the expertise of the team in many industries, including life sciences, energy, technology, and shipping. The ‘extremely talented, charismatic, and brilliant’ New York-qualified Tai-Heng Cheng leads the team, and is a ‘very effective advocate who reads the tribunal well’. Jennifer Lim and Meera Rajah are other key names in the team.
Testimonials
Collated independently by Legal 500 research team.
‘Sidley Austin is a blue chip dispute resolution and international arbitration practice and is led by the extremely talented, charismatic, and brilliant Tai-Heng Cheng.’
‘Tai-Heng Cheng is the consummate lawyer. Highly intelligent and formidable, he is world-class. Puts his heart into an assignment and is a very effective advocate who reads the tribunal well. A great person to have in your corner in any complex dispute.’
'Tai-Heng Cheng is well-versed in international arbitration and has great experience in investment arbitrations’
‘Sidley Austin provides prompt and excellent service.'
‘Partners Tai Heng-Chang and Jennifer Lim are highly recommended and very easy to work with.’
Key clients
- I-Mab Biopharma Co., Ltd.
- PACC Offshore Services Holdings (POSH)
- PT J ResourcesNusantara
- Tennor Holding B.V. (Lars Windhorst)
Work highlights
- Successfully represented PACC Offshore Services Holdings (POSH), part of the Kuok Group of Singapore, in an investment treaty arbitration against Mexico, administered by ICSID under the UNCITRAL Rules, in connection with the expropriation of claimant’s investment in the Mexican offshore marine services industry.
- Successfully represented PT J Resources Nusantara in a US$600 million SIAC arbitration against another Indonesian company Pani Bersama Tambang (PBT), a subsidiary of Indonesia’s Merdeka Copper Gold and secured a swift and favourable outcome for our client.
- Successfully represented life sciences company I-Mab Biopharma Co., Ltd. (“I-Mab”), a public company based in China and the U.S., in a multi-year long, hard fought, nine-figure international arbitration against Tracon Pharmaceuticals (“Tracon”).
Practice head
The lawyer(s) leading their teams.
Tai-Heng Cheng